Literature DB >> 31265686

Erratum: Evaluation of Safety and Efficacy of Salvage Therapy With Sunitinib, Docetaxel (Tyxane) and Cisplatinum Followed by Maintenance Vinorelbine for Unresectable/Metastatic Nonsmall Cell Lung Cancer: Stage 1 of a Simon 2 Stage Clinical Trial: Erratum.

.   

Abstract

[This corrects the article on p. e2303 in vol. 94, PMID: 26717366.].

Entities:  

Year:  2016        PMID： 31265686      PMCID： PMC4779044          DOI： 10.1097/01.md.0000481355.09097.27

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


In the article “Evaluation of Safety and Efficacy of Salvage Therapy With Sunitinib, Docetaxel (Tyxane) and Cisplatinum Followed by Maintenance Vinorelbine for Unresectable/Metastatic Nonsmall Cell Lung Cancer Stage 1 of a Simon 2 Stage Clinical Trial”,[1] which appeared in Volume 94, Issue 52 of Medicine, the word tyxan was spelled incorrectly as tyxane. The article has since been corrected online.
  1 in total

1.  Evaluation of Safety and Efficacy of Salvage Therapy With Sunitinib, Docetaxel (Tyxan) and Cisplatinum Followed by Maintenance Vinorelbine for Unresectable/Metastatic Nonsmall Cell Lung Cancer: Stage 1 of a Simon 2 Stage Clinical Trial. [Corrected].

Authors:  Cheng-Jeng Tai; Chien-Kai Wang; Chen-Jei Tai; Ching Tzao; Yung-Chang Lien; Chih-Cheng Hsieh; Cheng-I Hsieh; Hong-Cheng Wu; Chih-Hsiung Wu; Chun-Chao Chang; Ray-Jade Chen; Hung-Yi Chiou
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.